(0.33%) 5 116.92 points
(0.30%) 38 355 points
(0.38%) 15 988 points
(-0.86%) $83.13
(5.77%) $2.03
(0.45%) $2 357.80
(0.47%) $27.67
(3.91%) $958.15
(-0.22%) $0.933
(-0.37%) $10.98
(-0.55%) $0.796
(1.66%) $93.40
Live Chart Being Loaded With Signals
Chembio Diagnostics, Inc., together with its subsidiaries, develops, manufactures, and commercializes point-of-care (POC) diagnostic tests that are used to detect or diagnose diseases...
Stats | |
---|---|
本日の出来高 | 351 642 |
平均出来高 | 538 392 |
時価総額 | 16.71M |
EPS | $0 ( 2024-03-27 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.632 |
ATR14 | $0.0250 (5.49%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-03-11 | Angelico Paul | Buy | 29 333 | Common Stock |
2023-03-15 | Angelico Paul | Buy | 7 885 | Common Stock |
2023-03-15 | Angelico Paul | Sell | 2 843 | Common Stock |
2023-03-11 | Angelico Paul | Sell | 10 575 | Common Stock |
2023-03-11 | Angelico Paul | Sell | 29 333 | Restricted stock units |
INSIDER POWER |
---|
-90.29 |
Last 100 transactions |
Buy: 781 277 | Sell: 10 790 554 |
ボリューム 相関
Chembio Diagnostics Inc 相関
10 最も負の相関 | |
---|---|
ADXN | -0.922 |
MHUA | -0.913 |
AHPI | -0.898 |
BAFN | -0.898 |
SBNY | -0.89 |
ESPR | -0.889 |
RAIL | -0.888 |
KZR | -0.886 |
IGMS | -0.884 |
LOCO | -0.883 |
知っていましたか?
相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。
相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。
Chembio Diagnostics Inc 相関 - 通貨/商品
Chembio Diagnostics Inc 財務諸表
Annual | 2022 |
収益: | $48.34M |
総利益: | $9.76M (20.19 %) |
EPS: | $-0.960 |
FY | 2022 |
収益: | $48.34M |
総利益: | $9.76M (20.19 %) |
EPS: | $-0.960 |
FY | 2021 |
収益: | $47.82M |
総利益: | $13.32M (27.86 %) |
EPS: | $-1.400 |
FY | 2020 |
収益: | $30.45M |
総利益: | $6.58M (21.60 %) |
EPS: | $-1.340 |
Financial Reports:
No articles found.
Chembio Diagnostics Inc
Chembio Diagnostics, Inc., together with its subsidiaries, develops, manufactures, and commercializes point-of-care (POC) diagnostic tests that are used to detect or diagnose diseases. The company offers tests for COVID-19, HIV and Syphilis, and Zika virus. It also develops tests for malaria, dengue, chikungunya, Chagas, ebola, leishmaniasis, lassa, marburg, leptospirosis, rickettsia, and Burkholderia diseases. The company sells its products under the STAT-PAK, SURE CHECK, STAT VIEW, and DPP trademarks, as well as sells its products directly through distributors to medical laboratories and hospitals, governmental and public health entities, non-governmental organizations, medical professionals, and retail establishments in the United States and internationally. It has collaboration agreements with Bill & Melinda Gates Foundation, The Paul G. Allen Family Foundation, The Oswaldo Cruz Foundation, and the Foundation for Innovative New Diagnostics, as well as U.S. government agencies, such as Centers for Disease Control and Prevention, the Biomedical Advanced Research and Development Authority of the U.S. Department of Health and Human Services, and the U.S. Department of Agriculture. Chembio Diagnostics, Inc. was founded in 1985 and is headquartered in Hauppauge, New York.
について ライブシグナル
このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。